Clinical Trial
[Dopamine in patients with cardiogenic shock (author's transl)]
[Article in
German]
- PMID: 329088
Item in Clipboard
Clinical Trial
[Dopamine in patients with cardiogenic shock (author's transl)]
[Article in
German]
Med Klin.
.
Abstract
The effect of dopamine was tested in 20 patients with cardiogenic shock. 14 patients suffered from acute myocardial infarction, 6 patients from severe heart failure. In the beginning the dosis of dopamine was 200 to 300 microgram/min. 4 patients with an acute myocardial infarction died in shock. The remaining 10 patients survived the first shock symptomes. All patients with heart failure survived the cardiogenic shock. Hemodynamic studies showed a sigificant increase of the arterial mean pressure and a decrease of the diastolic arterial pulmonary pressure. During dopamine a statistically not significant increase of cardiac index and stroke volume was observed.
Similar articles
-
[The use of dopamin in shock and heart failure (author's transl)].Anaesthesist. 1978 Apr;27(4):183-6. Anaesthesist. 1978. PMID: 655365 German.
-
Hemodynamic and therapeutic effects of intravenous dopamine.Can Med Assoc J. 1977 Mar 19;116(6):645-8. Can Med Assoc J. 1977. PMID: 608165 Free PMC article.
-
[Hemodynamic study of dopamine used in chronic heart failures and in cardiogenic shock as a complication of acute myocardial infarct].Ann Anesthesiol Fr. 1975 Dec;16(9):669-72. Ann Anesthesiol Fr. 1975. PMID: 5028 French.
-
Pharmacologic support in cardiogenic shock.Adv Shock Res. 1983;10:35-49. Adv Shock Res. 1983. PMID: 6349299 Review.
-
["Cardiac power output" an old tool, possibly a modern tool for assessing cardiac pumping capability, as well as for a short-term prognosis in cardiogenic shock due to acute myocardial infarction].Arch Cardiol Mex. 2006 Jan-Mar;76(1):95-108. Arch Cardiol Mex. 2006. PMID: 16749510 Review. Spanish.